Concepcion M. G.
- Country
- Spain
- Department
- Pneumology
Research Overview
- Phase 3b/4 Randomized Double‑Blind Study of Depemokimab 100 mg SC Q26 weeks vs Placebo on Exacerbations and Lung‑Function Decline in Adults/Adolescents with Type 2 Asthma
- Non-Inferiority Trial of Depemokimab Versus Mepolizumab or Benralizumab in Severe Eosinophilic Asthma Patients
- Efficacy and Safety of Depemokimab vs. Mepolizumab in Adults with Relapsing/Refractory Eosinophilic Granulomatosis with Polyangiitis (EGPA)
Data & Insights
Has run more than one trial at 97 of 285 partner sites.
Specializations
Eosinophilic Conditions
The investigator specializes in treating various eosinophilic disorders, including Hypereosinophilic Syndrome (HES) and eosinophilic asthma. Their research extends to Eosinophilic Granulomatosis with Polyangiitis (EGPA), particularly focusing on relapsing or refractory cases.
- Hypereosinophilic Syndrome Management
- EGPA Treatment Approaches
- Eosinophilic Disease Therapeutics
The investigator evaluates novel therapeutic approaches for patients with these conditions who are receiving standard of care therapy.
Respiratory Medicine
This investigator has extensive experience in treating various forms of severe asthma, with particular emphasis on patients with eosinophilic phenotype. Their work includes research on both established and emerging treatments for inadequately controlled asthma.
- Severe Asthma Management
- Inhaler-Based Therapies
- Long-term Asthma Control
Their research encompasses both conventional and innovative therapeutic approaches for achieving optimal asthma control.
Chronic Cough Research
The investigator conducts research in the field of refractory chronic cough, including cases of unexplained chronic cough. Their work focuses on evaluating new therapeutic options for patients with persistent cough conditions.
- Refractory Cough Treatment
- Novel Cough Therapeutics
- Long-term Cough Management
The research involves assessment of innovative treatments for chronic cough conditions that have proven resistant to standard therapies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.